PMID- 22907530 OWN - NLM STAT- MEDLINE DCOM- 20130308 LR - 20141120 IS - 1460-2180 (Electronic) IS - 0143-3334 (Linking) VI - 33 IP - 12 DP - 2012 Dec TI - Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-kappaB and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor model. PG - 2520-8 LID - 10.1093/carcin/bgs265 [doi] AB - To evaluate the significance of C-C chemokine receptor type 5 (CCR5) in lung tumor development, we compared carcinogen-induced tumor growth in CCR5 knockout (CCR5(-/-)) mice and wild-type (CCR5(+/+)) mice. CCR5(-/-) mice showed reduced urethane (1g/kg)-induced tumor incidence when compared with those of CCR5(+/+) mice. We investigated the activation of nuclear factor-kappaB/STAT3 since these are implicated transcription factors in the regulation of genes involving tumor growth. Significant inhibition of DNA-binding activity of nuclear factor-kappaB and STAT3, and the translocation of p50 and p65 into the nucleus and the phosphorylation of IkB were found in the lungs of CCR5(-/-) mice compared with the lungs of CCR5(+/+) mice. Expression of apoptotic protein such as cleaved caspase-3, cleaved PARP and Bax was elevated, whereas the expression levels of survival protein such as Bcl-2 and cIAP1 was decreased in the lungs of CCR5(-/-) mice. Interestingly, we found that the level of monocyte chemoattractant protein-1 (MCP-1), a tumor growth-promoting cytokine, was significantly reduced in the lung tumor tissue and blood of CCR5(-/-) mice compared with the level in CCR5(+/+) mice. In addition, CCR5 small interfering RNA (siRNA) and inhibitor of MCP-1 blocked lung cancer cell growth, which was abolished by the addition of MCP-1 protein in cultured lung cancer cells. Moreover, inactivation of CD8(+) cytotoxic T cell and dendritic cells was significantly increased in the blood, lung tumors and spleens of CCR5(-/-) mice compared with that of CCR5(+/+) mice. Therefore, these results showed that CCR5 deficiency suppressed lung tumor development through the inhibition of nuclear factor-kappaB/STAT3 pathways and the downregulation of MCP-1 in the carcinogen-induced lung tumor model. FAU - Lee, Nam Jin AU - Lee NJ AD - College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju, 361-763, Korea. FAU - Choi, Dong Young AU - Choi DY FAU - Song, Ju Kyoung AU - Song JK FAU - Jung, Yu Yeon AU - Jung YY FAU - Kim, Dae Han AU - Kim DH FAU - Kim, Tae Myung AU - Kim TM FAU - Kim, Dae Joong AU - Kim DJ FAU - Kwon, Sun Mi AU - Kwon SM FAU - Kim, Kyung Bo AU - Kim KB FAU - Choi, Kyung Eun AU - Choi KE FAU - Moon, Dong Cheul AU - Moon DC FAU - Kim, Youngsoo AU - Kim Y FAU - Han, Sang Bae AU - Han SB FAU - Hong, Jin Tae AU - Hong JT LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120820 PL - England TA - Carcinogenesis JT - Carcinogenesis JID - 8008055 RN - 0 (CCR5 Receptor Antagonists) RN - 0 (Chemokine CCL2) RN - 0 (NF-kappa B) RN - 0 (Receptors, CCR5) RN - 0 (STAT3 Transcription Factor) RN - 3IN71E75Z5 (Urethane) SB - IM MH - Animals MH - Apoptosis MH - CCR5 Receptor Antagonists MH - CD8-Positive T-Lymphocytes/physiology MH - Chemokine CCL2/*antagonists & inhibitors MH - Dendritic Cells/physiology MH - Disease Models, Animal MH - Humans MH - Lung Neoplasms/chemically induced/pathology/*prevention & control MH - Mice MH - Mice, Inbred C57BL MH - NF-kappa B/*antagonists & inhibitors/physiology MH - Receptors, CCR5/*physiology MH - STAT3 Transcription Factor/physiology MH - Urethane/toxicity EDAT- 2012/08/22 06:00 MHDA- 2013/03/09 06:00 CRDT- 2012/08/22 06:00 PHST- 2012/08/22 06:00 [entrez] PHST- 2012/08/22 06:00 [pubmed] PHST- 2013/03/09 06:00 [medline] AID - bgs265 [pii] AID - 10.1093/carcin/bgs265 [doi] PST - ppublish SO - Carcinogenesis. 2012 Dec;33(12):2520-8. doi: 10.1093/carcin/bgs265. Epub 2012 Aug 20.